Wolters Kluwer Health has agreed to acquire AgileMD, a San Francisco-based provider of AI-powered clinical decision support, for up to US$100m, the Dutch information group said on 13 November 2026.
Why Wolters Kluwer Health (Wolters Kluwer N.V.) is buying AgileMD
Wolters Kluwer said AgileMD would help extend UpToDate into embedded EHR workflows and local hospital guidelines, complementing UpToDate Expert AI.
“We are excited to join Wolters Kluwer Health.”
Deal terms and financing
US$40m is payable upfront, with the balance deferred and contingent on performance targets. Wolters Kluwer expects an immaterial impact on adjusted earnings and a return on invested capital at or above its 8% after-tax weighted average cost of capital within three to five years.
Regulatory approvals and timing
Closing is expected in the first quarter of 2027 or sooner, subject to customary closing conditions and governmental approvals.
Market context
AgileMD was founded in 2011 by chief executive Borna Safabakhsh and chief medical officer Dana Edelson. Its eCART product is FDA-cleared for predicting inpatient deterioration.
